Literature DB >> 466209

Spread of steroid-containing foam after intrarectal administration.

D J Hay, H Sharma, M H Irving.   

Abstract

The spread of a steroid-containing foam from the rectum was studied in eight normal controls and eight patients with ulcerative colitis proved by biopsy. A standard dose of foam was labelled with technetium-99m adsorbed on to microspheres of Amberlite resin. Immediately after the foam was administered the extent of spread varied considerably, though in no instance did it extend beyond the rectosigmoid. Further scans at 120 and 240 minutes showed no further spread. It is concluded that a steroid-containing foam has a topical effect only on the rectal mucosa.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 466209      PMCID: PMC1599381          DOI: 10.1136/bmj.1.6180.1751

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  A local foam aerosol in ulcerative colitis.

Authors:  M L Clark
Journal:  Practitioner       Date:  1977-07

2.  Adjunctive use of a steroid rectal foam in the treatment of ulcerative colitis.

Authors:  N D Scherl; B A Scherl
Journal:  Dis Colon Rectum       Date:  1973 Mar-Apr       Impact factor: 4.585

  2 in total
  11 in total

1.  Colon targeted drug delivery systems: a review on primary and novel approaches.

Authors:  Anil K Philip; Betty Philip
Journal:  Oman Med J       Date:  2010-04

Review 2.  Medical treatment of ulcerative colitis.

Authors:  J E Lennard-Jones
Journal:  Postgrad Med J       Date:  1984-11       Impact factor: 2.401

3.  Spread of steroid-containing foam after intrarectal administration.

Authors:  M Irving
Journal:  Br Med J       Date:  1979-09-22

4.  Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis.

Authors:  M J Farthing; M D Rutland; M L Clark
Journal:  Br Med J       Date:  1979-10-06

Review 5.  Colon-targeted oral drug delivery systems: design trends and approaches.

Authors:  Seth Amidon; Jack E Brown; Vivek S Dave
Journal:  AAPS PharmSciTech       Date:  2015-06-13       Impact factor: 3.246

6.  Quantitative distribution of radiolabeled 5-aminosalicylic acid enemas in patients with left-sided ulcerative colitis.

Authors:  R A Vitti; F Meyers; L C Knight; J A Siegel; L S Malmud; R S Fisher
Journal:  Dig Dis Sci       Date:  1989-11       Impact factor: 3.199

7.  Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema.

Authors:  M Campieri; P Paoluzi; G D'Albasio; G Brunetti; A Pera; L Barbara
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

8.  Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis.

Authors:  M Campieri; C Corbelli; P Gionchetti; C Brignola; A Belluzzi; G Di Febo; P Zagni; G Brunetti; M Miglioli; L Barbara
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

9.  Pharmaceutical characterization of corticosteroid suppository treatment for ulcerative colitis.

Authors:  S Sadahiro; Z Ito; T Iijima; M Noguchi; K Hosoi
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

10.  Retrograde spreading of hydrocortisone enema in inflammatory bowel disease.

Authors:  M Jay; G A Digenis; T S Foster; D R Antonow
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.